Evidence map›Paper›PMID 26091628›Full record

ArticleIn vitro cellular & developmental biology. Animal2015

Maintenance of bladder urothelia integrity and successful urothelialization of various tissue-engineered mesenchymes in vitro.

Sara Bouhout, Julie Tremblay, Stephane Bolduc

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sara BouhoutCentre de recherche en organogénèse expérimentale de l'Université Laval/LOEX Faculté de médecine, Université Laval, Québec, Canada. sara.ucergy@hotmail.fr.
Julie TremblayService d'anatomopathologie du CHU de Québec, Québec, Canada.
Stephane BolducCentre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Faculté de médecine, Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada.

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Tissue-engineering offers the opportunity to produce hybrid tissues in vitro. The induction of bladder urothelial cells (BUCs) differentiation in vitro has been assessed by several research groups to build bladder models for fundamental studies and clinical applications. However, BUC induction of advanced differentiation in culture remains a challenging task. To reach this goal, optimal culture conditions are required, notably the use of specific additives as well as proper mesenchymal support. The best positive control for BUCs functional state monitoring is native urothelium collected from healthy bladder samples. In order to establish the best culture conditions to maintain and promote BUC differentiated state, native urothelia were cultured on various mesenchymes. Native bladder mesenchymes were used as controls for the maintenance of native urothelia. Histological and ultrastructural analyses showed the necessity to have a cellularized mesenchyme for rapid formation of a pseudostratified urothelium, allowing apical membrane rearrangement of the superficial cells in culture. Taken together, the results strongly suggest that it is possible to conserve the integrity of urothelia in vitro and, thus, potentially use them for eventual clinical applications and pharmacological investigations.

Indexed as

MesodermAnimalsCell Culture TechniquesCell DifferentiationCells, CulturedCulture MediaMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionMuscle, SmoothSus scrofaTissue EngineeringUrinary BladderUrotheliumCulture MediaBladder hybrid constructsCollagen matrixTissue-engineered urothelia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.